Insulin glargine, recombinant Subcutaneous and Trabectedin Intravenous
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Trabectedin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: trabectedin
Brand name: Yondelis
Synonyms: Trabectedin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Trace Elements
- Insulin glargine, recombinant Subcutaneous-Trace Elements 4 Injection
- Insulin glargine, recombinant Subcutaneous-Tracleer
- Insulin glargine, recombinant Subcutaneous-Tracleer (Bosentan Tablets for Oral Suspension)
- Insulin glargine, recombinant Subcutaneous-Tracleer (Bosentan Tablets)
- Insulin glargine, recombinant Subcutaneous-Tradjenta
- Trabectedin Intravenous-Insulin glulisine
- Trabectedin Intravenous-Insulin Glulisine (Cartridges and Pens)
- Trabectedin Intravenous-Insulin Glulisine (Vials)
- Trabectedin Intravenous-Insulin glulisine Subcutaneous
- Trabectedin Intravenous-Insulin human inhaled Inhalation
- Trabectedin Intravenous-Insulin human regular Injection